Blog Viewer

Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke

By Currents Editor posted 03-02-2020 10:13

  

Journal of the American Medical Association (02/20/20) doi: 10.1001/jama.2020.1511

Campbell, Bruce C. V.; Mitchell, Peter J.; Churilov, Leonid; et al.

While I.V. thrombolysis with tenecteplase is superior to alteplase in improving cerebral reperfusion in ischemic stroke patients, it was unknown if tenecteplase's performance is influenced by dose. To explore, researchers in Australia and New Zealand assembled a trial population of 300 adults with ischemic stroke caused by large vessel occlusion. Participants in the EXTEND-IA TNK study Part II were randomized by a ratio of 1:1 to receive either 0.40 mg/kg or 0.25 mg/kg of tenecteplase, administered as a bolus before endovascular thrombectomy. The primary endpoint was reperfusion of more than 50% of the involved ischemic territory before thrombectomy. The share of patients who satisfied this goal was 19.3% for both groups, signifying no additional benefit to giving patients a higher dose.

#LiteratureWatch

FURTHER READING
By Wade Smith, MD, PhD, FNCS, President, NCS Board of Directors, Professor of Neurology, UCSF; and Sharon C. Allen, NCS Executive Director As we end 2020, we open a new year with much anticipation for better world health. Many of you have qualified as Level 1A priority for COVID-19 vaccination and ...
By Matilda Dervisevic 1 , Chetan Sateesh Nayak 2  and Francisco Gomez 3 1 Univeristy of Missouri Medical School 2 Department of Neurology, University of Missouri 3 Department of Neurology, University of Missouri Refractory status epilepticus (RSE) is a condition in which there is continuing ...
By Eric Lawson, Masoom Desai and Aarti Sarwal Over the last decade, social media has revolutionized the connectivity of our medical community by providing a global, easily accessible and dynamic platform to share information. It has transformed into a vital, multi-purpose and widely accepted healthcare ...